XL168D, 5'-C*T*G*C*T*A*G*C*C*T*C*T*G*G*A*T*T*T*G*A-3', PS-DNA oligonucleotides.
XL168, same as XL168D, with a 5' biotin. XL169R, 5'-C*U*G*C*U*A*G*C*C*U*C*U*G*G*A*U*U*U*G*A, PS-RNA oligonucleotides with 2-O-methyl modification.
XL169, same as XL169R, with a 5' biotin.
XL183, 5'-rCrUrGrCrUrArGrCrCrUrCrUrGrGrArUrUrUrGrA-3', PO-RNA oligonucleotides. XL209-1, 5'-rC*rU*rG*rC*rU*rA*rG*rC*rC*rU*C*rU*rG*rG*rA*rU*rU*rU*rG*rA-3', PS-RNA oligonucleotide.
XL273, 5'-mCmUmGmCmUmAmGmCmCmUmCmUmGmGmAmUmUmUmGmA-3', 2'-methyl PO-RNA oligonucleotide.
390896, 5'-C*T*G*C*T*A*G*C*C*T*C*T*G*G*A*T*T*T*G*A-3', underlined are locked nucleic acids (LNA).
404130, 5'-C*T*G*C*T*A*G*C*C*T*C*T*G*G*A*T*T*T*G*A-3', the red nucleotides are 2'-fluorine modified.
110074 (NCL1), 5'-G*T*C*A*T*C*G*T*C*A*T*C*C*T*C*A*T*C*A*T, the underlined are 2'-MOE modified.
395254(Malat1), 5'-G*G*C*A*T*A*T*G*C*A*G*A*T*A*A*T*G*T*T*C, the underlined are 2'-MOE modified. 
Supplemental Figure legends
Figure S1. TCP1-β binds PS-but not PO-ASOs and is not present in the same ASO-protein complex with RNase H1. A) ASO-binding proteins were isolated using a PS-cEt ASO, and bound proteins were eluted by competition using ASOs containing different modifications, as indicated. Two third of eluted material was analyzed for Ku70 and TCP1β proteins by western analysis. The remaining material was separated on an 8%, 7M urea PAGE gel, and the presence of elution ASOs was determined by ethidium bromide staining. B) ASO-binding proteins (ASO-protein) were first enriched using a twostep affinity selection approach with PS-cEt-ASOs, and immunoprecipitation was performed from the ASO-protein pools using an RNaseH1 antibody (raised from rabbit, a gift kindly provided by Hongjiang Wu), or a GAPDH antibody (SC-25778, SCBT) as a negative control. The immunoprecipitated proteins were analyzed by western analysis for TCP1-ε (SC-376188, SCBT), TCP1-β (Ab119923, Abcam), and RNase H1 (Ab56560, Abcam). WC, 0.5% of whole cell extract used as input for ASO affinity selection. ASO-Protein, 10% of ASO-protein pool as used for immunoprecipitation. Figure S9 . The cytoplasmic PS-body-like structures do not co-localize with LAMP1 in RAN reduced cells upon PS-ASO transfection. RAN-depleted and control cells described in Fig. 6 were transfected with 60 nM PS-ASO ISIS446654 for 12 hr, and co-stained for TCP1-β (FITC) and LAMP1(AF647). The cytoplasmic PS-body-like structures contain TCP1-β and PS-ASOs, but not LAMP1 protein, as indicated by blue arrows. LAMP1 largely co-localizes with PS-ASOs (white colored dots in the merge panel), but not with TCP1-β protein (gray arrow head). The white arrow indicates a nuclear PS-body. Scale bars: 10 µm.
